LMC Diabetes Announces Collaboration with Leading Academic Researcher, Dr. Michael Riddell

TORONTO--()--LMC Diabetes & Endocrinology, the largest private Diabetes clinical research network in North America, announced their collaboration with Dr. Michael Riddell, PhD, a leading researcher in metabolic and hormonal responses to exercise and stress in diabetes.

The partnership brings academic and clinical expertise together to further explore the effect of exercise on diabetes.

"Diabetes is a complex disease, but there have been some pretty amazing advances through research," says Dr. Riddell. "By joining forces with LMC Diabetes as a Senior Scientist, we will have more direct input into the design of studies in order to generate higher quality, and more meaningful data."

As the search for new diabetes therapies continues, industry is turning to key opinion leaders for input on areas of focus that might prove most meaningful for patients. LMC's Endocrinologists currently provide direct care for over 50,000 active patients, including 24,500 patients with Type 2 diabetes, and 5,500 with Type 1 diabetes.

"With the continued advances in diabetes therapeutics and support devices, there is an expanded need to understand how these are impacting a diabetic's metabolic and hormonal responses during both exercise and daily life activities," said Karri Venn, President of Research at LMC. "Dr. Riddell is the right person to help us generate this information."

About Michael Riddell, PhD

Dr. Riddell is a Professor in the School of Kinesiology & Health Science and Muscle Health Research Centre at York University in Toronto. With funding from NIH, JDRF, NSERC and a variety of industry partners, Dr. Riddell's laboratory uses research techniques that span from cell culture to rodent and human studies to help discover how exercise, stress and diabetes influence energy metabolism. He has published over 120 original research papers and 18 book chapters and is the recipient of the Faculty of Health Dean's Established Career Research Award (2012). He is a contributing author to the Canadian Diabetes Association Clinical Practice Guidelines and to the International Society of Pediatric Diabetes Clinical Practice Consensus Guidelines.

Michael is also the Director of Education for the Diabetes Dskate Hockey and Type 1 Diabetes Program. Dr. Riddell is also a co-founder and Chair, Scientific Advisory Board for Zucara Therapeutics, advancing a novel technology that is showing promise as a new therapeutic approach to prevent hypoglycemia in people with diabetes who are insulin-dependent.

About LMC Diabetes & Endocrinology

LMC is an industry leader, providing Phase I-IV clinical trial services in 13 sites with 35 Endocrinologists, across four Canadian provinces. LMC Research is part of the LMC group of multi-disciplinary regional Centres of Excellence aimed at providing complete care in Diabetes, Endocrinology and Metabolism. Specific areas of interest in research primarily focuses in diabetes and all complications, cardiovascular & metabolic disease, osteoporosis and women's hormone health.

LMC Investigators have been repeatedly recognized as the top enrolling sites globally and have contributed as many as 560 subjects to a single diabetes study. To date, LMC has conducted over 600 clinical trials across its centers and is a recognized by Sanofi as one of their Diabetes Centers of Excellence.

www.lmc.ca | www.lmcresearch.com | www.mannaresearch.com

Contacts

LMC Diabetes & Manna Research
Karri Venn, 647-274-4133
President, Research
karri.venn@LMC.ca

Social Media Profiles

Contacts

LMC Diabetes & Manna Research
Karri Venn, 647-274-4133
President, Research
karri.venn@LMC.ca